Laboratory Corporation of America Holdings (LH)
NYSE · Healthcare · Diagnostics & Research
Laboratory Corporation of America Holdings is a Healthcare company with a market capitalization of $22.26B, a trailing P/E ratio of 24.1, and a dividend yield of 1.08%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $4.25 | $4.12 | +3.2% |
| Q4 2025 | February 17, 2026 | $4.07 | $3.94 | +3.3% |
| Q3 2025 | October 28, 2025 | $4.18 | $4.14 | +1.0% |
| Q2 2025 | July 24, 2025 | $4.35 | $4.16 | +4.6% |
| Q1 2025 | April 29, 2025 | $3.84 | $3.73 | +2.9% |
| Q4 2024 | February 6, 2025 | $3.45 | $3.39 | +1.8% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Laboratory Corporation of America Holdings's market cap?
As of June 29, 2026, Laboratory Corporation of America Holdings (LH) has a market capitalization of $22.26B.
What is Laboratory Corporation of America Holdings's P/E ratio?
Laboratory Corporation of America Holdings trades at a trailing price-to-earnings (P/E) ratio of 24.1. Its forward P/E is 15.2.
Does Laboratory Corporation of America Holdings pay a dividend?
Yes — Laboratory Corporation of America Holdings pays a dividend yielding 1.08%, an annual payout of $2.88 per share.
What sector is LH in?
Laboratory Corporation of America Holdings is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Laboratory Corporation of America Holdings's revenue?
In its latest reported fiscal year (ending December 31, 2025), Laboratory Corporation of America Holdings reported revenue of $13.95B and net income of $876.50M.
Ask your own questions about LH
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.